These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Cardiotoxicity in long term treatment with cytostatics (author's transl)]. Fuhrmann U, Rieger M, Franz Ch. Dtsch Med Wochenschr; 1978 Mar 03; 103(9):387-90. PubMed ID: 272983 [Abstract] [Full Text] [Related]
3. [Serial determination of anthracycline poisoning in children]. Stein JI, Langevin A, Benson LN, Souza MD, Wilson G, Chan H. Wien Klin Wochenschr; 1989 Jan 06; 101(1):45-8. PubMed ID: 2913725 [Abstract] [Full Text] [Related]
5. [Sudden death in leukemic patients treated with doxorubicin]. Lacasse Y, Bolduc P. Can J Cardiol; 1992 Jan 06; 8(1):53-6. PubMed ID: 1617512 [Abstract] [Full Text] [Related]
11. [Cardiotoxicity of anthracyclines in children. Contribution of anthracyclines in pediatric oncology]. Biron P, Philip T, Bouffet E, Favrot MC, Pinkerton R, Brunat-Mentigny M. Pathol Biol (Paris); 1987 Jan 06; 35(1):97-101. PubMed ID: 3550619 [Abstract] [Full Text] [Related]
12. [Myocardial hemorrhage due to high-dose cyclophosphamide treatment in a case of non-Hodgkin's lymphoma]. Yano S, Asai O, Kuraishi Y, Kobayashi T, Fujii T, Hirano A, Mizunuma N, Tada N, Dobashi N, Inamoto Y. Rinsho Ketsueki; 1993 Mar 06; 34(3):373-7. PubMed ID: 8479091 [Abstract] [Full Text] [Related]
13. [Ultrastructural study of cardiotoxicity and skin alterations in the golden hamster after treatment with 8 different anthracyclines]. Dantchev D, Slioussartchouk V, Paintrand M, Bourut C, Hayat M, Mathe G. C R Seances Soc Biol Fil; 1979 Mar 06; 173(2):394-413. PubMed ID: 159762 [Abstract] [Full Text] [Related]
14. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit. Jaenke RS, Deprez-DeCampeneere D, Trouet A. Cancer Res; 1980 Oct 06; 40(10):3530-6. PubMed ID: 6934026 [Abstract] [Full Text] [Related]
15. Risk factors for development of daunorubicin cardiotoxicity. Von Hoff DD, Layard M. Cancer Treat Rep; 1981 Oct 06; 65 Suppl 4():19-23. PubMed ID: 7049377 [Abstract] [Full Text] [Related]
16. Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma. Lopez M, Di Lauro L, Papaldo P, Ganzina F, Di Pietro N, Lazzaro B. Cancer Treat Rep; 1986 Jul 06; 70(7):911-2. PubMed ID: 3459575 [No Abstract] [Full Text] [Related]